Companies

Enliven Therapeutics, Inc. (ELVN) SEC filings

CIK 0001672619 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2021
Net income (USD)-71.6 M-37.7 M-41.4 M
Diluted EPS (USD/shares)-1.83-2.01-12.05

Latest filings

FiledFormDescriptionPeriod
2026-10-19144144
2026-10-16442026-10-14
2026-10-16332026-10-14
2026-10-148-K8-K items 5.02,7.01,9.012026-10-14
2026-10-05442026-10-01
2026-10-01144144
2026-09-21442026-09-17
2026-09-21442026-09-17
2026-09-17144144
2026-09-04144144
2026-08-19442026-08-17
2026-08-19442026-08-17
2026-08-06442026-08-04
2026-08-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-08-04144144
2026-07-21442026-07-17
2026-07-21442026-07-17
2026-07-17144144
2026-07-08442026-07-06
2026-06-24442026-06-22
2026-06-24SCHEDULE 13D/ASCHEDULE 13D/A
2026-06-22144144
2026-06-22144144

Forms on file (last 1,000): 4 324, 144 157, 8-K 56, 3 45, SC 13G/A 23, 10-Q 20, SCHEDULE 13G/A 15, SC 13G 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ELVN (0.002 USD), /gw/filings/filings?ticker=ELVN&form=8-K, /gw/filings/facts?ticker=ELVN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange